NCT01263691: Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults |
|
|
| Completed | 1 | 105 | US | BioThrax, Anthrax Vaccine Adsorbed (AVA), AV7909 Formulation 1, AV7909 Formulation 2, AV7909 Formulation 3, AV7909 Formulation 4, Control | Emergent BioSolutions, National Institute of Allergy and Infectious Diseases (NIAID), Department of Health and Human Services | Bacillus Anthracis (Anthrax) Infection | 05/12 | 06/12 | | |
